On ‘Psychology Behind the Headlines,’ hosts Jessica Reyes, Patricia Wu, and guest therapist Ryan Heapy discuss about the new drug that can reduce the risk of severe depression in new mothers.
What is esketamine?
A nasal spray related to ketamine, with antidepressant properties.
Study shows potential
Women who received esketamine were less likely to need serious depression care after childbirth.
Global impact
The study highlights a shift towards innovative mental health treatment options.
